Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells
Many mitotic kinases have been targeted for the development of anti-cancer drugs, and inhibitors of these kinases have been expected to perform well for cancer therapy. Efforts focused on selecting good targets and finding specific drugs to target are especially needed, largely due to the increased...
Main Authors: | Kim, Seong-Hoon, Ryu, Hye Guk, Lee, Juhyun, Shin, Joon, Harikishore, Amaravadhi, Jung, Hoe-Youn, Kim, Ye Seul, Lyu, Ha-Na, Oh, Eunji, Baek, Nam-In, Choi, Kwan-Yong, Yoon, Ho Sup, Kim, Kyong-Tai |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Journal Article |
Language: | English |
Published: |
2015
|
Online Access: | https://hdl.handle.net/10356/103986 http://hdl.handle.net/10220/38799 |
Similar Items
-
Luteolin suppresses cancer cell proliferation by targeting vaccinia-related kinase 1
by: Kim, Ye Seul, et al.
Published: (2014) -
Obtusilactone B from Machilus Thunbergii targets barrier-to-autointegration factor to treat cancer
by: Kim, Wanil, et al.
Published: (2014) -
Revisiting De Novo drug design : receptor based pharmacophore screening
by: Yoon, Ho Sup, et al.
Published: (2015) -
Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells
by: Kang, Tae-Hong, et al.
Published: (2012) -
The flavonoid myricetin reduces nocturnal melatonin levels in the blood through the inhibition of serotonin N-acetyltransferase
by: Shin, Jae-Cheon, et al.
Published: (2013)